Lv5
876 积分 2023-06-02 加入
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
7天前
已完结
Neuroimmunometabolic co-evolution in the tumor micro- and macroenvironment
7天前
已完结
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
8天前
已完结
Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma
8天前
已完结
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
8天前
已完结
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
9天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
9天前
已完结
Spatial Multi-omics Analyses Reveal Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Induced Neutrophil Extracellular Trap Formation
22天前
已完结
YY1-glycolytic axis promotes high glucose-induced cancer stemness in endometrial cancer: A multi-omics guided therapeutic strategy
1个月前
已完结
A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial
2个月前
已完结
皖公网安备34019202002308
